Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Optimization of the proliferation and persistency of CAR T cells derived from human induced pluripotent stem cells
Tatsuki Ueda, Sara Shiina, Shoichi Iriguchi, et al.
Nature Biomedical Engineering (2022)
Open Access | Times Cited: 50

Showing 1-25 of 50 citing articles:

CAR-T cell manufacturing: Major process parameters and next-generation strategies
Melanie Ayala Ceja, Mobina Khericha, Caitlin Harris, et al.
The Journal of Experimental Medicine (2024) Vol. 221, Iss. 2
Open Access | Times Cited: 70
Exploring the promising potential of induced pluripotent stem cells in cancer research and therapy
Matin Chehelgerdi, Fereshteh Behdarvand Dehkordi, Mohammad Chehelgerdi, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 68
Revolutionizing cancer treatment: enhancing CAR-T cell therapy with CRISPR/Cas9 gene editing technology
Ruiyu Tao, Xiaopeng Han, Xue Bai, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 31
New cell sources for CAR-based immunotherapy
Marzieh Mazinani, Fatemeh Rahbarizadeh
Biomarker Research (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 25
Engineered T cells from induced pluripotent stem cells: from research towards clinical implementation
Ratchapong Netsrithong, Laura García-Pérez, Maria Themeli
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 12
Cancer immunotherapy by γδ T cells
Adrian Hayday, Julie Déchanet‐Merville, Jamie Rossjohn, et al.
Science (2024) Vol. 386, Iss. 6717
Open Access | Times Cited: 9
Engineered stem cell-based strategy: A new paradigm of next-generation stem cell product in regenerative medicine
Han Han, Bi‐Te Chen, Liu Yang, et al.
Journal of Controlled Release (2023) Vol. 365, pp. 981-1003
Closed Access | Times Cited: 20
Harnessing the evolving CRISPR/Cas9 for precision oncology
Tianye Li, Shuiquan Li, Yue Kang, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 8
Allogeneic chimeric antigen receptor cell therapies for cancer: progress made and remaining roadblocks
Caroline Diorio, David T. Teachey, Stephan A. Grupp
Nature Reviews Clinical Oncology (2024)
Closed Access | Times Cited: 8
CRISPR-Cas gene knockouts to optimize engineered T cells for cancer immunotherapy
Valentine De Castro, Jeanne Galaine, Romain Loyon, et al.
Cancer Gene Therapy (2024) Vol. 31, Iss. 8, pp. 1124-1134
Closed Access | Times Cited: 6
Allogeneic chimeric antigen receptor T cells for children with relapsed/refractory B-cell precursor acute lymphoblastic leukemia
Franco Locatelli, Francesca Del Bufalo, Concetta Quintarelli
Haematologica (2024) Vol. 109, Iss. 6, pp. 1689-1699
Open Access | Times Cited: 6
Strength of CAR signaling determines T cell versus ILC differentiation from pluripotent stem cells
Suwen Li, Chloe S. Wang, Amélie Montel‐Hagen, et al.
Cell Reports (2023) Vol. 42, Iss. 3, pp. 112241-112241
Open Access | Times Cited: 13
PX-478, an HIF-1α inhibitor, impairs mesoCAR T cell antitumor function in cervical cancer
Ahmad Reza Panahi Meymandi, Behnia Akbari, Tahereh Soltantoyeh, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 5
Application Prospect of Induced Pluripotent Stem Cells in Organoids and Cell Therapy
Teng Zhang, Cheng Qian, Mengyao Song, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 2680-2680
Open Access | Times Cited: 5
Universal CAR 2.0 to overcome current limitations in CAR therapy
Lara Sophie Schlegel, Coralie Werbrouck, Michael Boettcher, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 5
Advancements in adoptive CAR immune cell immunotherapy synergistically combined with multimodal approaches for tumor treatment
Yun Chang, Ming‐Yang Chang, Xiaoping Bao, et al.
Bioactive Materials (2024) Vol. 42, pp. 379-403
Open Access | Times Cited: 5
Generating hematopoietic cells from human pluripotent stem cells: approaches, progress and challenges
Haiqiong Zheng, Yijin Chen, Qian Luo, et al.
Cell Regeneration (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 11
Natural killer cell therapy: the key to tackle the bottleneck of cell therapies against solid tumor?
Dawei Wu, Huilei Miao, Xiaoxue Ma, et al.
Science Bulletin (2025)
Closed Access
Current Landscape of Adoptive Cell Therapy and Challenge to Develop “Off‐The‐Shelf” Therapy for Hepatocellular Carcinoma
Seung Kak Shin, Y. Mishima, Yoonseok Lee, et al.
Journal of Gastroenterology and Hepatology (2025)
Open Access
Targeting BCL11B in CAR-engineered lymphoid progenitors drives NK-like cell development with prolonged anti-leukemic activity
Franziska Baatz, Arnab Ghosh, Jessica Herbst, et al.
Molecular Therapy (2025)
Closed Access
Resistance to Immunotherapy in Non-small Cell Lung Cancer: Unraveling Causes, Developing Effective Strategies, and Exploring Potential Breakthroughs
Shuang Dong, Xiaoyu Li, Qing Huang, et al.
Drug Resistance Updates (2025) Vol. 81, pp. 101215-101215
Closed Access
Progress and challenges in developing allogeneic cell therapies
T. Deuse, Sonja Schrepfer
Cell stem cell (2025) Vol. 32, Iss. 4, pp. 513-528
Open Access
Immune mediated inflammatory diseases: moving from targeted biologic therapy, stem cell therapy to targeted cell therapy
Zhihou Liang, Hui Xie, Dongze Wu
Frontiers in Immunology (2025) Vol. 16
Open Access
Advances in Gene Therapy with Oncolytic Viruses and CAR-T Cells and Therapy-Related Groups
Yasunari Matsuzaka, Ryu Yashiro
Current Issues in Molecular Biology (2025) Vol. 47, Iss. 4, pp. 268-268
Open Access
Induced Pluripotent Stem Cells-Based Regenerative Therapies in Treating Human Aging-Related Functional Decline and Diseases
P. W. Yu, Bin Liu, Cheng Dong, et al.
Cells (2025) Vol. 14, Iss. 8, pp. 619-619
Open Access
Page 1 - Next Page

Scroll to top